5,464
Views
9
CrossRef citations to date
0
Altmetric
Reproductive Medicine

Cost-effectiveness analysis of carbetocin versus oxytocin for the prevention of postpartum hemorrhage following vaginal birth in the United Kingdom

, ORCID Icon, ORCID Icon &
Pages 129-137 | Received 09 Aug 2021, Accepted 07 Jan 2022, Published online: 20 Jan 2022

References

  • WHO. WHO recommendations; uterotonics for the prevention of postpartum haemorrhage. Geneva: World Health Organisation; 2018.
  • Mavrides E, Allard S, Chandraharan E, et al. Prevention and management of postpartum haemorrhage. BJOG. 2016;124:e106–e149.
  • Say L, Chou D, Gemmill A, et al. Global causes of maternal death: a WHO systematic analysis. Lancet Glob Health. 2014;2(6):e323-33–e333.
  • Reale SC, Easter SR, Xu X, et al. Trends in postpartum hemorrhage in the United States from 2010 to 2014. Anesth Analg. 2020;130(5):e119–e122.
  • Ford JB, Patterson JA, Seeho SK, et al. Trends and outcomes of postpartum haemorrhage, 2003-2011. BMC Pregnancy Childbirth. 2015;15:334.
  • Callaghan WM, Kuklina EV, Berg CJ. Trends in postpartum hemorrhage: United States, 1994-2006. Am J Obstet Gynecol. 2010;202(4):353.e1-6–353.e6.
  • Knight M, Callaghan WM, Berg C, et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the international postpartum hemorrhage collaborative Group. BMC Pregnancy Childbirth. 2009;9:55.
  • Lutomski JE, Byrne BM, Devane D, et al. Increasing trends in atonic postpartum haemorrhage in Ireland: an 11-year population-based cohort study. BJOG. 2012;119(3):306–314.
  • Mehrabadi A, Hutcheon JA, Lee L, et al. Epidemiological investigation of a temporal increase in atonic postpartum haemorrhage: a population-based retrospective cohort study. BJOG. 2013;120(7):853–862.
  • Bateman BT, Berman MF, Riley LE, et al. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth Anal. 2010;110(5):1368–1373.
  • Carroli G, Cuesta C, Abalos E, et al. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract Res Clin Obstet Gynaecol. 2008;22(6):999–1012.
  • Kayem G, Dupont C, Bouvier-Colle MH, et al. Invasive therapies for primary postpartum haemorrhage: a population-based study in France. BJOG. 2016;123(4):598–605.
  • Sentilhes L, Gromez A, Clavier E, et al. Long-term psychological impact of severe postpartum hemorrhage. Acta Obstet Gynecol Scand. 2011;90(6):615–620.
  • WHO, UNICEF, UNFPA, et al. Trends in maternal mortality: 1990 to 2015: estimates by WHO, UNICEF, UNFPA, world bank group and the united nationas population division. Geneva: World Health Organisation; 2015.
  • WHO. WHO recommendations for the prevention and treatment of postpartum haemorrhage. Geneva: World Health Organisation; 2012.
  • Rasheed SM, Amin MM, Abd Ellah AH, et al. Reproductive performance after conservative surgical treatment of postpartum hemorrhage. Int J Gynaecol Obstet. 2014;124(3):248–252.
  • Sathe NA, Likis FE, Young JL, et al. Procedures and uterine-sparing surgeries for managing postpartum hemorrhage: a systematic review. Obstet Gynecol Surv. 2016;71(2):99–113.
  • Hollier-Hann G, Richardson J, von Wilamowitz-Moellendorff CM, et al. Healthcare resource use for the management of postpartum haemorrhage in France, Italy, The Netherlands, and the UK. Value in Health. 2019;22(Supplement 3):S635.
  • van der Nelson HA, Draycott T, Siassakos D, et al. Carbetocin versus oxytocin for prevention of post-partum haemorrhage at caesarean section in the United Kingdom: an economic impact analysis. Eur J Obstet Gynecol Reprod Biol. 2017;210:286–291.
  • Richardson J, Hollier-Hann G, Kelly K, et al. A study of the healthcare resource use for the management of postpartum haemorrhage in France, Italy, The Netherlands, and the UK. Eur J Obstet Gynecol Reprod Biol. 2021;268:92–99.
  • NICE. Care in third stage of labour: National Institute for Health and Care Excellence; 2021. [updated 2021 Apr 20; cited 2021 Oct 15]. Available from: https://pathways.nice.org.uk/pathways/intrapartum-care/care-in-third-stage-of-labour.
  • Gallos ID, Papadopoulou A, Man R, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;2018(12):CD011689.
  • Malm M, Madsen I, Kjellstrom J. Development and stability of a heat-stable formulation of carbetocin for the prevention of postpartum haemorrhage for use in low and middle-income countries. J Pept Sci. 2018;24(6):e3082.
  • Rath W. Prevention of postpartum haemorrhage with the oxytocin analogue carbetocin. Eur J Obstet Gynecol Reprod Biol. 2009;147(1):15–20.
  • Gallos ID, Williams HM, Price MJ, et al. Uterotonic agents for preventing postpartum haemorrhage: a network meta-analysis. Cochrane Database Syst Rev. 2018;4:CD011689.
  • Office for National Statistics. Dataset: births by parents' characteristics. England and Wales: Office for National Statistics; 2017. [cited 2019 May 1]. Available from: https://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/livebirths/datasets/birthsbyparentscharacteristics.
  • Knight M, Nair M, Tuffnell D. Saving lives, improving mothers’ care lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2013–15. Oxford: National Perinatal Epidemiology Unit; 2017.
  • Knight M, Bunch K, Tuffnell D, et al. Saving lives, improving mother's care: lessons learned to inform maternity care from the UK and Ireland confidential enquiries into maternal deaths and morbidity 2014–16. Oxford: National Perinatal Epidemiology Unit, University of Oxford; 2018.
  • Widmer M, Piaggio G, Nguyen TMH, et al. Heat-Stable carbetocin versus oxytocin to prevent hemorrhage after vaginal Birth. N Engl J Med. 2018;379(8):743–752.
  • Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst Rev. 2012;15(2):CD005457.
  • National Health Service. Department of Health Reference Costs 2018–19. 2019. [cited 2019 Mar]. Available from: https://improvement.nhs.uk/resources/reference-costs/.
  • Monthly Index of Medical Specialities. Drug costs. MIMS; 2020. [cited 2020 Jan]. Available from: http://www.mims.co.uk.
  • National Health Service. Department of Health Reference Costs 2017–18. 2018. [cited 2019 Mar]. Available from: https://improvement.nhs.uk/resources/reference-costs/.
  • Curtis L. Unit Costs of Health and Social Care 2019. 2019. [cited 2020 Jan]. Available from: https://www.pssru.ac.uk/project-pages/unit-costs/unit-costs-2019/.
  • Lee D, Thornton P, Hirst A, et al. Cost effectiveness of romiplostim for the treatment of chronic immune thrombocytopenia in Ireland. Appl Health Econ Health Policy. 2013;11(5):457–469.
  • Gallos ID, Williams H, Price M, et al. Uterotonic drugs to prevent postpartum haemorrhage: a network meta-analysis. Health Technol Assess. 2019;23(9):1–356.
  • Henríquez-Trujillo AR, Lucio-Romero RA, Bermúdez-Gallegos K. Analysis of the cost-effectiveness of carbetocin for the prevention of hemorrhage following cesarean delivery in Ecuador. J Comp Eff Res. 2017;6(6):529–536.
  • Voon HY, Shafie AA, Bujang MA, et al. Cost effectiveness analysis of carbetocin during cesarean section in a high volume maternity unit. J Obstet Gynaecol Res. 2018;44(1):109–116.
  • Caceda SI, Ramos RR, Saborido CM. Pharmacoeconomic study comparing carbetocin with oxytocin for the prevention of hemorrhage following cesarean delivery in Lima, Peru. J Comp Eff Res. 2018;7(1):49–55.
  • Al Wattar BH, Tamblyn JA, Parry-Smith W, et al. Management of obstetric postpartum hemorrhage: a national service evaluation of current practice in the UK. RMHP. 2017;10:1–6. 01/17
  • Embrey MP. Simultaneous intramuscular injection of oxytocin and ergometrine: a tocographic study. Br Med J. 1961;1(5241):1737–1738.
  • Hunter DJ, Schulz P, Wassenaar W. Effect of carbetocin, a long-acting oxytocin analog on the postpartum uterus. Clin Pharmacol Ther. 1992;52(1):60–67.